NutriSense, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
NutriSense, Inc. - overview
Established
2019
Location
Chicago, IL, US
Primary Industry
Medical Devices & Equipment
About
Founded in 2019 by its CEO, Alex Skryl, and based in Illinois, US, NutriSense, Inc. operates as a health technology platform that monitors blood glucose levels. In July 2022, NutriSense, Inc. raised USD 25 million in series A funding led by a new investor, 1315 Capital.
The company offers a digital health care platform that helps users with real-time glucose tracking, meal composition data, fasting and meal timing, physical activity and exercise routines, stress and sleep, and habits and routines. The company plans to use the July 2022 funding to expand its operations and program.
Current Investors
1315 Capital
Primary Industry
Medical Devices & Equipment
Sub Industries
Education & Training Services, Healthcare IT, Diagnostic Equipment, Monitoring Equipment
Website
www.nutrisense.io
Verticals
HealthTech, Manufacturing
Company Stage
Series A
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.